Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial-Reference-Cited by-同舟云学术

Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial

Published:2022-12 Issue:6 Volume:80 Page:810-813
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Polkinghorne Kevan R.,Wetmore James B.,Thao Le Thi Phuong,Wolfe Rory,Woods Robyn L.,Ernst Michael E.,Nelson Mark R.,Reid Christopher M.,Shah Raj C.,McNeil John J.,Murray Anne M.

Publisher

Elsevier BV

Subject

Nephrology

Reference10 articles.

1. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

2. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement;Davidson;JAMA,2022

3. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly;McNeil;N Engl J Med,2018

4. Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney;Harris;Trans Am Clin Climatol Assoc,2013

5. Effect of aspirin on renal disease progression in patients with type 2 diabetes: a multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design;Violi;Am Heart J,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study;Journal of Diabetes Investigation;2023-12-21

2. Association of long-term aspirin use with kidney disease progression;Frontiers in Medicine;2023-12-04